Cargando…

Reduction of Fat to Muscle Mass Ratio Is Associated with Improvement of Liver Stiffness in Diabetic Patients with Non-Alcoholic Fatty Liver Disease

Body weight reduction leads to improvement of nonalcoholic fatty liver disease (NAFLD), but the contributions of body composition modification on its improvement have not been clarified yet. We performed a retrospective cohort study in a Japanese university hospital to clarify the effect of body fat...

Descripción completa

Detalles Bibliográficos
Autores principales:	Osaka, Takafumi, Hashimoto, Yoshitaka, Okamura, Takuro, Fukuda, Takuya, Yamazaki, Masahiro, Hamaguchi, Masahide, Fukui, Michiaki
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2019
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6947171/ https://www.ncbi.nlm.nih.gov/pubmed/31835362 http://dx.doi.org/10.3390/jcm8122175

Ejemplares similares

The sodium-glucose cotransporter 2 inhibitor luseogliflozin can suppress muscle atrophy in Db/Db mice by suppressing the expression of foxo1
por: Okamura, Takuro, et al.
Publicado: (2019)

Nonalcoholic fatty liver disease remission in men through regular exercise
por: Osaka, Takafumi, et al.
Publicado: (2018)

Changes in metabolic complications in patients with alcoholic fatty liver disease monitored over two decades: NAGALA study
por: Hamaguchi, Masahide, et al.
Publicado: (2020)

Clinical characteristics and longitudinal changes of patients with non-alcoholic fatty liver disease in 2 decades: the NAGALA study
por: Okamura, Takuro, et al.
Publicado: (2021)

Effect of alcohol consumption and the presence of fatty liver on the risk for incident type 2 diabetes: a population-based longitudinal study
por: Okamura, Takuro, et al.
Publicado: (2020)

Metabolic associated fatty liver disease is a risk factor for chronic kidney disease
por: Hashimoto, Yoshitaka, et al.
Publicado: (2021)

Obesity and metabolic abnormalities as risks of alcoholic fatty liver in men: NAGALA study
por: Yoshimura, Yuta, et al.
Publicado: (2021)

A weight regain of 1.5 kg or more and lack of exercise are associated with nonalcoholic fatty liver disease recurrence in men
por: Nakanishi, Naoko, et al.
Publicado: (2021)

Relationship between serum creatinine to cystatin C ratio and subclinical atherosclerosis in patients with type 2 diabetes
por: Hashimoto, Yoshitaka, et al.
Publicado: (2022)

Nonoverweight nonalcoholic fatty liver disease and incident cardiovascular disease: A post hoc analysis of a cohort study
por: Yoshitaka, Hashimoto, et al.
Publicado: (2017)

Dietary Fiber Intake Is Related to Skeletal Muscle Mass, Body Fat Mass, and Muscle-to-Fat Ratio Among People With Type 2 Diabetes: A Cross-Sectional Study
por: Takahashi, Fuyuko, et al.
Publicado: (2022)

The Association of Salt Intake and Non-alcoholic Fatty Liver Disease in People With Type 2 Diabetes: A Cross-Sectional Study
por: Takahashi, Fuyuko, et al.
Publicado: (2022)

Trans Fatty Acid Intake Induces Intestinal Inflammation and Impaired Glucose Tolerance
por: Okamura, Takuro, et al.
Publicado: (2021)

Creatinine to Body Weight Ratio Is Associated with Incident Diabetes: Population-Based Cohort Study
por: Hashimoto, Yoshitaka, et al.
Publicado: (2020)

Correlation between Liver Stiffness by Two-Dimensional Shear Wave Elastography and Waist Circumference in Japanese Local Citizens with Abdominal Obesity
por: Miyoshi, Tomoki, et al.
Publicado: (2021)

Japanese radio calisthenics prevents the reduction of skeletal muscle mass volume in people with type 2 diabetes
por: Kimura, Tomonori, et al.
Publicado: (2020)

ILC2s Improve Glucose Metabolism Through the Control of Saturated Fatty Acid Absorption Within Visceral Fat
por: Okamura, Takuro, et al.
Publicado: (2021)

Group 3 Innate Lymphoid Cells Protect Steatohepatitis From High-Fat Diet Induced Toxicity
por: Hamaguchi, Masahide, et al.
Publicado: (2021)

A Pilot Study on the Effect of Anti-Thrombopoietin Antibody on Platelet Count in Patients with Type 2 Diabetes
por: Fukuda, Takuya, et al.
Publicado: (2020)

Eating Fast Is Associated with Nonalcoholic Fatty Liver Disease in Men But Not in Women with Type 2 Diabetes: A Cross-Sectional Study
por: Takahashi, Fuyuko, et al.
Publicado: (2020)

Erythritol Ameliorates Small Intestinal Inflammation Induced by High-Fat Diets and Improves Glucose Tolerance
por: Kawano, Rena, et al.
Publicado: (2021)

Non-alcoholic fatty liver disease with obesity as an independent predictor for incident gastric and colorectal cancer: a population-based longitudinal study
por: Hamaguchi, Masahide, et al.
Publicado: (2019)

Understanding of antidiabetic medication is associated with blood glucose in patients with type 2 diabetes: At baseline date of the KAMOGAWA‐DM cohort study
por: Sakai, Ryosuke, et al.
Publicado: (2018)

Let-7e-5p Regulates IGF2BP2, and Induces Muscle Atrophy
por: Okamura, Takuro, et al.
Publicado: (2021)

The Triglyceride and Glucose Index Is a Predictor of Incident Nonalcoholic Fatty Liver Disease: A Population-Based Cohort Study
por: Kitae, Aya, et al.
Publicado: (2019)

Effect of Teriparatide on Bone Mineral Density and Trabecular Bone Score in Type 2 Diabetic Patients with Osteoporosis: A Retrospective Cohort Study
por: Munekawa, Chihiro, et al.
Publicado: (2022)

Handgrip measurement as a useful benchmark for locomotive syndrome in patients with type 2 diabetes mellitus: A KAMOGAWA‐DM cohort study
por: Kitagawa, Noriyuki, et al.
Publicado: (2020)

Triglyceride–glucose index (TyG index) is a predictor of incident colorectal cancer: a population-based longitudinal study
por: Okamura, Takuro, et al.
Publicado: (2020)

Visceral Adiposity Index is a predictor of incident colorectal cancer: a population-based longitudinal study
por: Okamura, Takuro, et al.
Publicado: (2020)

Oral Exposure to Polystyrene Microplastics of Mice on a Normal or High-Fat Diet and Intestinal and Metabolic Outcomes
por: Okamura, Takuro, et al.
Publicado: (2023)

Favorable Appendicular Skeletal Muscle Mass Changes in Older Patients With Type 2 Diabetes Receiving GLP-1 Receptor Agonist and Basal Insulin Co-Therapy
por: Osaka, Takafumi, et al.
Publicado: (2023)

Asymptomatic postprandial hypotension in patients with diabetes: The KAMOGAWA‐HBP study
por: Kitae, Aya, et al.
Publicado: (2020)

Effects of probiotic Bifidobacterium bifidum G9‐1 on the gastrointestinal symptoms of patients with type 2 diabetes mellitus treated with metformin: An open‐label, single‐arm, exploratory research trial
por: Hata, Shinnosuke, et al.
Publicado: (2021)

Relative low muscle mass and muscle strength is associated with the prevalence of metabolic syndrome in patients with type 2 diabetes
por: Takegami, Maya, et al.
Publicado: (2022)

Low circulating arachidonic acid is associated with macroalbuminuria in diabetic patients: a cross-sectional examination of the KAMOGAWA-DM cohort study
por: Okamura, Takuro, et al.
Publicado: (2021)

Association between the frequency of toothbrushing and lifestyle in people with type 2 diabetes mellitus: at the baseline date of the Kamogawa-DM cohort study
por: Saijo, Yuto, et al.
Publicado: (2021)

Extracellular lipidome change by an SGLT2 inhibitor, luseogliflozin, contributes to prevent skeletal muscle atrophy in db/db mice
por: Bamba, Ryo, et al.
Publicado: (2021)

Impact of Eating Speed on Muscle Mass in Older Patients With Type 2 Diabetes: A Prospective Study of KAMOGAWA–DM Cohort
por: Kobayashi, Genki, et al.
Publicado: (2022)

Dipeptidyl peptidase-4 inhibitors have adverse effects for the proliferation of human T cells
por: Kitagawa, Noriyuki, et al.
Publicado: (2018)

Microbe‐associated metabolites as targets for incident type 2 diabetes
por: Hashimoto, Yoshitaka, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_qu4qjlncucvn2p13n84dv96t33